MedDataX Logo

Echo-Cardiographic Assessment of Cardiovascular Characteristics During Pregnancy and Postpartum Periods

NCT ID: NCT00522977

Last Updated: 2008-02-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-08-31

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this echocardiographic study is to restudy the longitudinal changes in cardiac size and function during and after pregnancy in healthy women using relatively new parameters of systolic and diastolic function as well as classical measures of left ventricle (LV) function using contemporary echocardiographic machines.

We, the researchers at Hillel Yaffe Medical Center, will assess diastolic function and its possible relation to shortness of breath.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A comprehensive echocardiographic study of the heart will be conducted in the first, second and third trimesters of pregnancy and 3 months postpartum.

Determination of left ventricular dimensions, transvalvular Doppler flow, ejection fraction, stroke volume, cardiac output, pulmonary vein flow, tissue Doppler, flow propagation, global and segmental strain parameters, timing of peak strain and various parameters of diastolic function will be obtained.

From these data normal values for various stages of pregnancy will be determined as well as range for changes expected during longitudinal follow-up will be determined.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Myocardial strain Myocardial function Pregnancy Postpartum Echocardiography Myocardial adaptation to pregnancy Systolic function Diastolic function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy women
* First trimester of a normal pregnancy
* Normal baseline echocardiogram

Exclusion Criteria

* Pregnancy with more than one fetus.
* Any hemodynamically significant cardiac condition
* Any known systemic disease
* Poor quality echocardiogram
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hillel Yaffe Medical Center

OTHER_GOV

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David S Blondheim, MD

Role: PRINCIPAL_INVESTIGATOR

Hillel Yaffe Medical Center

Asnat Walfisch, MD

Role: PRINCIPAL_INVESTIGATOR

Hillel Yaffe Medical Center

Mordechai Hallak, Prof.

Role: STUDY_CHAIR

Hillel Yaffe Medical Center

Avraham Shotan, MD

Role: STUDY_DIRECTOR

Hillel Yaffe Medical Center

Kazatzker Mark, MD

Role: PRINCIPAL_INVESTIGATOR

Hillel Yaffe Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hille Yaffe Medical Center

Hadera, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David S Blondheim, MD

Role: CONTACT

Phone: 972-4630-4488

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

David S Blondheim, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BLOND1CTIL

Identifier Type: -

Identifier Source: org_study_id